Interstitial pneumonitis following autologous bone marrow transplantation

Interstitial pneumonitis (IP) occurred in 20 of 143 (14%) patients who received cytoreductive therapy followed by autologous bone marrow transplantation (BMT) as treatment for malignancy. IP occurred at a median onset time of 41 days (5 to 624 days). All but three of the episodes were fatal. Of the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Transplantation 1988-07, Vol.46 (1), p.61-65
Hauptverfasser: WINGARD, J. R, SOSTRIN, M. B, VRIESENDORP, H. M, MELLITS, E. D, SANTOS, G. W, FULLER, D. J, BRAINE, H. G, YEAGER, A. M, BURNS, W. H, SARAL, R
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 65
container_issue 1
container_start_page 61
container_title Transplantation
container_volume 46
creator WINGARD, J. R
SOSTRIN, M. B
VRIESENDORP, H. M
MELLITS, E. D
SANTOS, G. W
FULLER, D. J
BRAINE, H. G
YEAGER, A. M
BURNS, W. H
SARAL, R
description Interstitial pneumonitis (IP) occurred in 20 of 143 (14%) patients who received cytoreductive therapy followed by autologous bone marrow transplantation (BMT) as treatment for malignancy. IP occurred at a median onset time of 41 days (5 to 624 days). All but three of the episodes were fatal. Of the thirteen cases in which tissue was examined, half were idiopathic; the remainder were due to various infectious agents. The actuarial incidences of idiopathic (7%) and CMV IP (2%) in these marrow autograft recipients were lower than the incidences of idiopathic (19%) and CMV IP (17%) in comparably treated recipients of allogeneic BMT (P less than or equal to 0.001 for both comparisons).
doi_str_mv 10.1097/00007890-198807000-00010
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78320603</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>14967545</sourcerecordid><originalsourceid>FETCH-LOGICAL-c486t-ce14e74b2684515947e8a20f32fc1cfab0f340f1cdb2f27b4709ca146b51d5ef3</originalsourceid><addsrcrecordid>eNqFkN9LwzAQgIMoc07_BKEP4lv1rkma9FGGPwYDX_S5pFkyKmlTm5Thf290c68GQnLcd5fLR0iGcIdQiXtIS8gKcqykBJGiPG2EEzJHTllegoRTMgdgmCOl4pxchPCREE6FmJFZIWlVIZ-T1aqPZgyxja1y2dCbqfN9CkJmvXN-1_bbTE3RO7_1U8ga35usU-Pod1kcVR8Gp_qoYuv7S3JmlQvm6nAuyPvT49vyJV-_Pq-WD-tcM1nGXBtkRrCmKCXjyCsmjFQFWFpYjdqqJl0ZWNSbprCFaJiASitkZcNxw42lC3K77zuM_nMyIdZdG7RxaRCTRqyFpAWUQP8FkVWl4IwnUO5BPfoQRmPrYWzTJ79qhPpHd_2nuz7qrn91p9LrwxtT05nNsfDgN-VvDnkVtHI2KdNtOGICKBYA9BsyZIjY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>14967545</pqid></control><display><type>article</type><title>Interstitial pneumonitis following autologous bone marrow transplantation</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>WINGARD, J. R ; SOSTRIN, M. B ; VRIESENDORP, H. M ; MELLITS, E. D ; SANTOS, G. W ; FULLER, D. J ; BRAINE, H. G ; YEAGER, A. M ; BURNS, W. H ; SARAL, R</creator><creatorcontrib>WINGARD, J. R ; SOSTRIN, M. B ; VRIESENDORP, H. M ; MELLITS, E. D ; SANTOS, G. W ; FULLER, D. J ; BRAINE, H. G ; YEAGER, A. M ; BURNS, W. H ; SARAL, R</creatorcontrib><description>Interstitial pneumonitis (IP) occurred in 20 of 143 (14%) patients who received cytoreductive therapy followed by autologous bone marrow transplantation (BMT) as treatment for malignancy. IP occurred at a median onset time of 41 days (5 to 624 days). All but three of the episodes were fatal. Of the thirteen cases in which tissue was examined, half were idiopathic; the remainder were due to various infectious agents. The actuarial incidences of idiopathic (7%) and CMV IP (2%) in these marrow autograft recipients were lower than the incidences of idiopathic (19%) and CMV IP (17%) in comparably treated recipients of allogeneic BMT (P less than or equal to 0.001 for both comparisons).</description><identifier>ISSN: 0041-1337</identifier><identifier>EISSN: 1534-6080</identifier><identifier>DOI: 10.1097/00007890-198807000-00010</identifier><identifier>PMID: 2839915</identifier><identifier>CODEN: TRPLAU</identifier><language>eng</language><publisher>Hagerstown, MD: Lippincott</publisher><subject>Adolescent ; Adult ; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Biological and medical sciences ; Bone Marrow Transplantation ; Bone marrow, stem cells transplantation. Graft versus host reaction ; Child ; Child, Preschool ; Cytomegalovirus Infections - complications ; Female ; Humans ; Leukemia - therapy ; Lymphoma - therapy ; Male ; Medical sciences ; Pulmonary Fibrosis - etiology ; Risk Factors ; Transfusions. Complications. Transfusion reactions. Cell and gene therapy ; Virus Diseases - complications</subject><ispartof>Transplantation, 1988-07, Vol.46 (1), p.61-65</ispartof><rights>1989 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c486t-ce14e74b2684515947e8a20f32fc1cfab0f340f1cdb2f27b4709ca146b51d5ef3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=7031200$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2839915$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>WINGARD, J. R</creatorcontrib><creatorcontrib>SOSTRIN, M. B</creatorcontrib><creatorcontrib>VRIESENDORP, H. M</creatorcontrib><creatorcontrib>MELLITS, E. D</creatorcontrib><creatorcontrib>SANTOS, G. W</creatorcontrib><creatorcontrib>FULLER, D. J</creatorcontrib><creatorcontrib>BRAINE, H. G</creatorcontrib><creatorcontrib>YEAGER, A. M</creatorcontrib><creatorcontrib>BURNS, W. H</creatorcontrib><creatorcontrib>SARAL, R</creatorcontrib><title>Interstitial pneumonitis following autologous bone marrow transplantation</title><title>Transplantation</title><addtitle>Transplantation</addtitle><description>Interstitial pneumonitis (IP) occurred in 20 of 143 (14%) patients who received cytoreductive therapy followed by autologous bone marrow transplantation (BMT) as treatment for malignancy. IP occurred at a median onset time of 41 days (5 to 624 days). All but three of the episodes were fatal. Of the thirteen cases in which tissue was examined, half were idiopathic; the remainder were due to various infectious agents. The actuarial incidences of idiopathic (7%) and CMV IP (2%) in these marrow autograft recipients were lower than the incidences of idiopathic (19%) and CMV IP (17%) in comparably treated recipients of allogeneic BMT (P less than or equal to 0.001 for both comparisons).</description><subject>Adolescent</subject><subject>Adult</subject><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>Biological and medical sciences</subject><subject>Bone Marrow Transplantation</subject><subject>Bone marrow, stem cells transplantation. Graft versus host reaction</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Cytomegalovirus Infections - complications</subject><subject>Female</subject><subject>Humans</subject><subject>Leukemia - therapy</subject><subject>Lymphoma - therapy</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Pulmonary Fibrosis - etiology</subject><subject>Risk Factors</subject><subject>Transfusions. Complications. Transfusion reactions. Cell and gene therapy</subject><subject>Virus Diseases - complications</subject><issn>0041-1337</issn><issn>1534-6080</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1988</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkN9LwzAQgIMoc07_BKEP4lv1rkma9FGGPwYDX_S5pFkyKmlTm5Thf290c68GQnLcd5fLR0iGcIdQiXtIS8gKcqykBJGiPG2EEzJHTllegoRTMgdgmCOl4pxchPCREE6FmJFZIWlVIZ-T1aqPZgyxja1y2dCbqfN9CkJmvXN-1_bbTE3RO7_1U8ga35usU-Pod1kcVR8Gp_qoYuv7S3JmlQvm6nAuyPvT49vyJV-_Pq-WD-tcM1nGXBtkRrCmKCXjyCsmjFQFWFpYjdqqJl0ZWNSbprCFaJiASitkZcNxw42lC3K77zuM_nMyIdZdG7RxaRCTRqyFpAWUQP8FkVWl4IwnUO5BPfoQRmPrYWzTJ79qhPpHd_2nuz7qrn91p9LrwxtT05nNsfDgN-VvDnkVtHI2KdNtOGICKBYA9BsyZIjY</recordid><startdate>19880701</startdate><enddate>19880701</enddate><creator>WINGARD, J. R</creator><creator>SOSTRIN, M. B</creator><creator>VRIESENDORP, H. M</creator><creator>MELLITS, E. D</creator><creator>SANTOS, G. W</creator><creator>FULLER, D. J</creator><creator>BRAINE, H. G</creator><creator>YEAGER, A. M</creator><creator>BURNS, W. H</creator><creator>SARAL, R</creator><general>Lippincott</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>19880701</creationdate><title>Interstitial pneumonitis following autologous bone marrow transplantation</title><author>WINGARD, J. R ; SOSTRIN, M. B ; VRIESENDORP, H. M ; MELLITS, E. D ; SANTOS, G. W ; FULLER, D. J ; BRAINE, H. G ; YEAGER, A. M ; BURNS, W. H ; SARAL, R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c486t-ce14e74b2684515947e8a20f32fc1cfab0f340f1cdb2f27b4709ca146b51d5ef3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1988</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>Biological and medical sciences</topic><topic>Bone Marrow Transplantation</topic><topic>Bone marrow, stem cells transplantation. Graft versus host reaction</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Cytomegalovirus Infections - complications</topic><topic>Female</topic><topic>Humans</topic><topic>Leukemia - therapy</topic><topic>Lymphoma - therapy</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Pulmonary Fibrosis - etiology</topic><topic>Risk Factors</topic><topic>Transfusions. Complications. Transfusion reactions. Cell and gene therapy</topic><topic>Virus Diseases - complications</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>WINGARD, J. R</creatorcontrib><creatorcontrib>SOSTRIN, M. B</creatorcontrib><creatorcontrib>VRIESENDORP, H. M</creatorcontrib><creatorcontrib>MELLITS, E. D</creatorcontrib><creatorcontrib>SANTOS, G. W</creatorcontrib><creatorcontrib>FULLER, D. J</creatorcontrib><creatorcontrib>BRAINE, H. G</creatorcontrib><creatorcontrib>YEAGER, A. M</creatorcontrib><creatorcontrib>BURNS, W. H</creatorcontrib><creatorcontrib>SARAL, R</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Transplantation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>WINGARD, J. R</au><au>SOSTRIN, M. B</au><au>VRIESENDORP, H. M</au><au>MELLITS, E. D</au><au>SANTOS, G. W</au><au>FULLER, D. J</au><au>BRAINE, H. G</au><au>YEAGER, A. M</au><au>BURNS, W. H</au><au>SARAL, R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Interstitial pneumonitis following autologous bone marrow transplantation</atitle><jtitle>Transplantation</jtitle><addtitle>Transplantation</addtitle><date>1988-07-01</date><risdate>1988</risdate><volume>46</volume><issue>1</issue><spage>61</spage><epage>65</epage><pages>61-65</pages><issn>0041-1337</issn><eissn>1534-6080</eissn><coden>TRPLAU</coden><abstract>Interstitial pneumonitis (IP) occurred in 20 of 143 (14%) patients who received cytoreductive therapy followed by autologous bone marrow transplantation (BMT) as treatment for malignancy. IP occurred at a median onset time of 41 days (5 to 624 days). All but three of the episodes were fatal. Of the thirteen cases in which tissue was examined, half were idiopathic; the remainder were due to various infectious agents. The actuarial incidences of idiopathic (7%) and CMV IP (2%) in these marrow autograft recipients were lower than the incidences of idiopathic (19%) and CMV IP (17%) in comparably treated recipients of allogeneic BMT (P less than or equal to 0.001 for both comparisons).</abstract><cop>Hagerstown, MD</cop><pub>Lippincott</pub><pmid>2839915</pmid><doi>10.1097/00007890-198807000-00010</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0041-1337
ispartof Transplantation, 1988-07, Vol.46 (1), p.61-65
issn 0041-1337
1534-6080
language eng
recordid cdi_proquest_miscellaneous_78320603
source MEDLINE; Journals@Ovid Complete
subjects Adolescent
Adult
Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy
Biological and medical sciences
Bone Marrow Transplantation
Bone marrow, stem cells transplantation. Graft versus host reaction
Child
Child, Preschool
Cytomegalovirus Infections - complications
Female
Humans
Leukemia - therapy
Lymphoma - therapy
Male
Medical sciences
Pulmonary Fibrosis - etiology
Risk Factors
Transfusions. Complications. Transfusion reactions. Cell and gene therapy
Virus Diseases - complications
title Interstitial pneumonitis following autologous bone marrow transplantation
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T10%3A41%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Interstitial%20pneumonitis%20following%20autologous%20bone%20marrow%20transplantation&rft.jtitle=Transplantation&rft.au=WINGARD,%20J.%20R&rft.date=1988-07-01&rft.volume=46&rft.issue=1&rft.spage=61&rft.epage=65&rft.pages=61-65&rft.issn=0041-1337&rft.eissn=1534-6080&rft.coden=TRPLAU&rft_id=info:doi/10.1097/00007890-198807000-00010&rft_dat=%3Cproquest_cross%3E14967545%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=14967545&rft_id=info:pmid/2839915&rfr_iscdi=true